Articles dans des revues avec comité de lecture (260)
132.
Lefranc, F., Decaestecker, C., Brotchi, J., Heizmann, C. W., De Witte, O., Kiss, R., & Mijatovic, T. (2005). Co-expression/co-location of S100 proteins (S100B, S100A1 and S100A2) and protein kinase C (PKC-beta, -eta and -zeta) in a rat model of cerebral basilar artery vasospasm. Neuropathology and applied neurobiology, 31(6), 649-660. doi:10.1111/j.1365-2990.2005.00682.x133.
Saal, I., Nagy, N., Lensch, M., Lohr, M., Manning, J. C., Decaestecker, C., André, S., Kiss, R., Salmon, I., & Gabius, H.-J. (2005). Human galectin-2: expression profiling by RT-PCR/immunohistochemistry and its introduction as a histochemical tool for ligand localization. Histology and histopathology, 20(4), 1191-1208.134.
Mathieu, A., Saal, I., Vuckovic, A., Ransy, V., Vereerstraeten, P., Kaltner, H., Gabius, H.-J., Kiss, R., Decaestecker, C., Salmon, I., & Remmelink, M. (2005). Nuclear galectin-3 expression is an independent predictive factor of recurrence for adenocarcinoma and squamous cell carcinoma of the lung. Modern pathology, 18(9), 1264-1271. doi:10.1038/modpathol.3800416135.
Camby, I., Decaestecker, C., Lefranc, F., Kaltner, H., Gabius, H.-J., & Kiss, R. (2005). Galectin-1 knocking down in human U87 glioblastoma cells alters their gene expression pattern. Biochemical and biophysical research communications, 335(1), 27-35. doi:10.1016/j.bbrc.2005.07.037136.
Darro, F., Decaestecker, C., Gaussin, J.-F., Mortier, S., Van Ginckel, R., & Kiss, R. (2005). Are syngeneic mouse tumor models still valuable experimental models in the field of anti-cancer drug discovery? International journal of oncology, 27(3), 607-616.138.
Lefranc, F., Mijatovic, T., Decaestecker, C., Kaltner, H., André, S., Brotchi, J., Salmon, I., Gabius, H.-J., & Kiss, R. (2005). Monitoring the expression profiles of integrins and adhesion/growth-regulatory galectins in adamantinomatous craniopharyngiomas: their ability to regulate tumor adhesiveness to surrounding tissue and their contribution to prognosis. Neurosurgery, 56(4), 763-776.139.
Van Quaquebeke, E., Simon, G., André, A., Dewelle, J., El Yazidi, M., Bruyneel, F., Tuti, J., Nacoulma, O., Guissou, P., Decaestecker, C., Braekman, J. C., Kiss, R., & Darro, F. (2005). Identification of a novel cardenolide (2''-oxovoruscharin) from Calotropis procera and the hemisynthesis of novel derivatives displaying potent in vitro antitumor activities and high in vivo tolerance: structure-activity relationship analyses. Journal of medicinal chemistry, 48(3), 849-856. doi:10.1021/jm049405a140.
Remmelink, M., Mijatovic, T., Gustin, A., Mathieu, A., Rombaut, K., Kiss, R., Salmon, I., & Decaestecker, C. (2005). Identification by means of cDNA microarray analyses of gene expression modifications in squamous non-small cell lung cancers as compared to normal bronchial epithelial tissue. International journal of oncology, 26(1), 247-258.141.
D'Haene, N., Maris, C., Sandras, F., Dehou, M. F., Remmelink, M., Decaestecker, C., & Salmon, I. (2005). The differential expression of Galectin-1 and Galectin-3 in normal lymphoid tissue and non-Hodgkin's and Hodgkin's lymphomas. International journal of immunopathology and pharmacology, 18(3), 431-443.142.
Lefranc, F., Mijatovic, T., Mathieu, V., Rorive, S., Decaestecker, C., Debeir, O., Brotchi, J., Van Ham, P., Salmon, I., & Kiss, R. (2004). Characterization of gastrin-induced proangiogenic effects in vivo in orthotopic U373 experimental human glioblastomas and in vitro in human umbilical vein endothelial cells. Clinical cancer research, 10(24), 8250-8265. doi:10.1158/1078-0432.CCR-04-0343